Floatz logo

Donor Lymphocyte Preparation Depleted Of Host Functional Alloreactive T-Cells

Myelodysplastic Syndrome

Kiadis PharmaCell therapyPhase 2/3Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
73/ 100

Competitive context

315 Active assets in the Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB
ALLOGENEIC, EX VIVO EXPANDED, UMBILICAL CORD BLOOD-DERIVED HEMATOPOIETIC CD133+ PROGENITOR CELLS- CULTURED FRACTION (CF)
Gamida Cell ltd
Phase 3BB

View all 50 →

Same molecule, other indications

Donor Lymphocyte Preparation Depleted Of Host Functional Alloreactive T-Cells is also rated in:

acute lymphoblastic leukemiaDormant
CCC
Indicative ·
55 / 100
View asset →
myeloproliferative neoplasmDormant
CCC
Indicative ·
55 / 100
View asset →
myeloid leukemiaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →